시장보고서
상품코드
1855885

세계의 기능 유전체학 시장 보고서(2025년)

Functional Genomics Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

기능 유전체학 시장 규모는 최근 급속히 확대하고 있습니다. 2024년 129억 6,000만 달러에서 2025년에는 148억 4,000만 달러로, CAGR 14.5%로 확대합니다. 이 기간의 성장은 유전자 발현 연구의 중요성 증가, 신약개발에서 기능적 분석의 활용도 증가, 생명공학 기업의 확대, 하이스루풋 스크리닝 방법의 연구개발, 유전체학 연구에서의 바이오인포매틱스 통합의 발전 등에 기인합니다.

기능유전체학 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다. 2029년에는 연평균 14.2%의 연평균 복합 성장률(CAGR)로 251억 9,000만 달러로 성장할 것입니다. 예측 기간 중의 성장은 정밀의료에 대한 투자 증가, 멀티오믹스 접근법의 광범위한 채택, 고급 유전자 검사에 대한 수요 증가, 종양학에서 기능유전체학의 적용 확대, 연구개발에 대한 투자 확대에 기인합니다. 예측 기간의 주요 동향으로는 단일세포 시퀀싱 기술의 발전, 클라우드 기반 유전체 데이터 플랫폼의 개발, 고처리량 기능 스크리닝 방법의 혁신, 유전체학과 단백질체학 통합의 진전, 기능 유전체학을 이용한 개인 맞춤형 치료 접근법의 등장 등을 들 수 있습니다. 등이 있습니다.

기능유전체학은 유전자와 유전체의 다른 요소들이 생물체 내에서 어떻게 기능하고 상호작용하는지에 초점을 맞춘 연구 분야입니다. 그 목적은 생물학적 과정을 조절하는 유전자의 역할과 유전자가 형질과 행동에 어떤 영향을 미치는지 이해하는 것입니다. 기능유전체학은 유전자 발현 패턴과 유전적 변이의 영향을 분석함으로써 세포, 조직, 생물 전체를 조절하는 메커니즘을 규명합니다.

기능유전체학의 주요 제품은 키트와 분석 및 기기입니다. 키트 및 분석은 특정 생체 분자, 유전자, 단백질을 식별, 측정, 분석하기 위해 개발된 표준화된 실험실 툴입니다. 차세대염기서열분석(NGS), 마이크로어레이 분석, CRISPR 및 유전자 편집 기술, RNA 시퀀싱(RNA-seq) 등의 기술을 채택하여 학계 및 연구기관, 제약 및 바이오 제약기업, 의약품 개발 업무 위탁기관(CRO), 임상검사기관, 농업생명공학 기업 등 다양한 최종사용자에 의해 이용되고 있습니다.

2025년 봄 미국의 갑작스러운 관세 인상과 이에 따른 무역 마찰은 헬스케어 분야, 특히 중요한 의료기기, 진단기기, 의약품공급에 심각한 영향을 미치고 있습니다. 병원과 의료 서비스 프로바이더들은 수입 수술기구, 영상 진단 장비, 주사기, 카테터 등 소모품의 비용 상승에 직면해 있습니다. 이러한 비용 상승은 의료 예산을 압박하고 있으며, 일부 의료기관은 장비 업그레이드를 늦추거나 환자에게 비용을 전가하고 있습니다. 또한 원자재 및 부품에 대한 관세는 필수적인 의약품 및 의료기기의 생산을 방해하여 공급망 병목현상을 유발하고 있습니다. 이에 대해 업계는 조달 전략을 다양화하고, 가능한 한 현지 생산을 촉진하고, 생명을 구하는 의료 제품에 대한 관세 면제를 옹호하고 있습니다.

이 보고서는 기능유전체학 산업 세계 시장 규모, 지역별 점유율, 기능유전체학 시장 점유율을 보유한 경쟁사, 상세한 기능유전체학 시장 부문, 시장 동향 및 비즈니스 기회, 기능유전체학 산업에서 성공하기 위해 필요한 데이터 등 기능유전체학 시장 통계를 제공합니다. Business Research Company의 새로운 보고서 시리즈 중 하나입니다. 이 기능 유전체학 시장 조사 보고서는 업계의 현재와 미래 시나리오에 대한 상세한 분석을 통해 필요한 모든 것을 완벽하게 제공합니다.

연구개발에 대한 투자 증가는 기능유전체학 시장의 큰 폭의 성장을 가속할 것으로 예측됩니다. 연구개발은 연구와 실험을 통해 제품, 프로세스, 지식을 창조, 개선, 혁신하기 위한 체계적인 노력입니다. 기업은 경쟁력을 유지하기 위해 신제품 개발, 기술 발전, 새로운 시장 기회 확보에 점점 더 많은 자원을 투입하고 있습니다. 이러한 투자 증가는 유전자 기능의 식별과 분석을 촉진하고, 복잡한 생물학적 과정에 대한 이해를 높이고, 표적 치료 전략 개발을 지원함으로써 기능 유전체학에 혜택을 가져다주고 있습니다. 예를 들어 2022년 12월 영국 보건사회부는 신생아 희귀 유전병 진단을 가속화하고 생명을 구하는 치료를 제공하기 위해 1억 5천만 파운드(약 2,000억 원)를 투자할 것이라고 발표했습니다. 이번 자금 조달은 환자의 DNA를 조사하여 유전체 헬스케어 연구를 강화하고 기능유전체학 시장의 성장을 더욱 촉진할 것입니다.

기능 유전체학 시장의 주요 기업은 하이스루풋 시퀀싱과 같은 첨단 기술에 집중하고 있습니다. 이 방법을 통해 대량의 DNA와 RNA를 신속하고 동시에 시퀀싱할 수 있으며, 광범위한 유전자 분석이 가능합니다. 예를 들어 스위스에 본사를 둔 제약회사 로슈는 2025년 2월 획기적인 차세대 시퀀싱 방법인 SBX(sequencing by expansion) 기술을 발표했습니다. SBX 케미스트리는 첨단 센서 모듈과 결합하여 다양한 용도에 적응하고 확장 가능한 초고속, 고처리량 시퀀싱을 가능하게 합니다. 이 혁신적인 기술은 DNA 또는 RNA 서열을 원래의 핵산보다 50배 더 긴 Xpandomer라는 검출 가능한 폴리머로 변환합니다. 이 프로세스는 명확한 검출을 위한 강력하고 저잡음의 신호를 생성하고, 병렬 처리를 위해 CMOS 기반 센서를 활용하며, 놀라운 속도와 다용도로 고정밀도의 1 분자 나노포어 시퀀싱을 달성합니다.

2022년 11월, 미국 의료기기 제조업체인 바이오케어 메디컬(Biocare Medical)은 엠파이어 제네믹스(Empire Genomics)를 인수하여 기능유전체학 역량을 확대했습니다. 이번 인수는 바이오케어의 분자진단 및 기능유전체학 전문성을 강화하기 위한 것으로, 100만개 이상의 바이오마커 포트폴리오와 신속한 바이오마커 개발을 기존 진단 플랫폼에 통합하는 것을 목표로 하고 있습니다. 이를 통해 바이오케어는 암 연구 및 개인 맞춤형 진단 지원 역량을 강화할 수 있게 되었습니다. 미국에 본사를 둔 엠파이어 제네믹스(Empire Genomics)는 기능유전체학을 전문으로 하는 회사로, Biocare의 성장 역량에 전문성을 더할 수 있게 되었습니다.

기능유전체학 시장은 유전자 발현 프로파일링, 후성유전체 프로파일링, 표현형 스크리닝, 변이효과 분석 등의 서비스를 제공하는 사업체의 매출으로 구성됩니다. 시장 가치에는 서비스 프로바이더가 판매하거나 서비스 제공에 포함된 관련 상품의 가치도 포함됩니다. 기능유전체학 시장에는 마이크로어레이 스캐너, 서멀사이클러, 플루오로미터, 바이오분석기 등의 매출도 포함됩니다. 이 시장의 가치는 '팩토리 게이트(공장 출고 시)' 가치입니다. 즉, 상품의 생산자 또는 제작자가 다른 사업체(다운스트림 생산자, 도매업체, 유통업체, 소매업체 등) 또는 최종 고객에게 직접 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품을 만든 사람이 판매하는 관련 서비스도 포함됩니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계의 기능 유전체학 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
  • 최종 용도 산업의 분석
  • 세계의 기능 유전체학 시장 : 성장률 분석
  • 세계의 기능 유전체학 시장 실적 : 규모와 성장, 2019-2024
  • 세계의 기능 유전체학 시장 예측 : 규모와 성장, 2024-2029, 2034F
  • 세계의 기능 유전체학 : TAM(Total Addressable Market)

제6장 시장 세분화

  • 세계의 기능 유전체학 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 키트 및 어세이
  • 기기
  • 세계의 기능 유전체학 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 차세대 시퀸서(NGS)
  • 마이크로어레이 분석
  • CRISPR와 유전자 편집 기술
  • RNA 시퀀스(RNA-Seq)
  • 단백질체학
  • 세계의 기능 유전체학 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 학술연구기관
  • 제약·바이오의약품 기업
  • 계약 연구기관(CROs)
  • 임상 연구소
  • 농업 바이오테크놀러지 기업
  • 세계의 기능 유전체학 시장 : 서브 세분화 키트 및 어세이, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • PCR 키트
  • 마이크로어레이 키트
  • NGS 키트
  • 시약
  • 효소
  • 세계의 기능 유전체학 시장 : 서브 세분화 기기, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 시퀸서
  • 마이크로어레이 스캐너
  • PCR 기기
  • 자동화 시스템

제7장 지역별·국가별 분석

  • 세계의 기능 유전체학 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
  • 세계의 기능 유전체학 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 기능 유전체학 시장 : 경쟁 구도
  • 기능 유전체학 시장 : 기업 개요
    • Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 대기업과 혁신적 기업

  • Illumina Inc.
  • Perkin Elmer Inc.
  • Revvity Inc.
  • Exact Sciences Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Integrated DNA Technologies Inc.
  • Promega Corporation
  • Pacific Biosciences of California Inc.
  • Genomics Ltd.
  • MEDiC LLC
  • Enhanc3D Genomics Ltd.
  • Samplix
  • Arima Genomics Inc.
  • Phase Genomics Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

  • 기능 유전체학 시장 2029 : 새로운 기회를 제공하는 국가
  • 기능 유전체학 시장 2029 : 새로운 기회를 제공하는 부문
  • 기능 유전체학 시장 2029 : 성장 전략
    • 시장 동향에 기반한 전략
    • 경쟁사 전략

제36장 부록

KSA 25.11.12

Functional genomics is the field of study focused on how genes and other elements of the genome function and interact within an organism. Its goal is to understand the roles of genes in regulating biological processes and how they impact traits and behaviors. By analyzing patterns of gene expression and the effects of genetic variations, functional genomics uncovers the mechanisms that control cells, tissues, and entire organisms.

The main products in functional genomics are kits and assays and instruments. Kits and assays are standardized laboratory tools developed to identify, measure, or analyze specific biomolecules, genes, or proteins. It employs technologies such as next-generation sequencing (NGS), microarray analysis, CRISPR and gene editing technologies, and RNA sequencing (RNA-seq), and is utilized by various end-users, including academic and research institutes, pharmaceutical and biopharmaceutical companies, contract research organizations (CROs), clinical laboratories, and agricultural biotechnology companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The functional genomics market research report is one of a series of new reports from The Business Research Company that provides functional genomics market statistics, including functional genomics industry global market size, regional shares, competitors with a functional genomics market share, detailed functional genomics market segments, market trends and opportunities, and any further data you may need to thrive in the functional genomics industry. This functional genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The functional genomics market size has grown rapidly in recent years. It will grow from $12.96 billion in 2024 to $14.84 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to the increasing emphasis on gene expression studies, rising use of functional assays in drug discovery, expansion of biotech firms, development of high-throughput screening methods, and growing integration of bioinformatics in genomics research.

The functional genomics market size is expected to see rapid growth in the next few years. It will grow to $25.19 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increasing investments in precision medicine, wider adoption of multi-omics approaches, rising demand for advanced genetic testing, expanding applications of functional genomics in oncology, and greater investment in research and development. Key trends in the forecast period include advancements in single-cell sequencing technologies, development of cloud-based genomic data platforms, innovation in high-throughput functional screening methods, progress in integrating genomics with proteomics, and the emergence of personalized therapeutic approaches using functional genomics.

The growing investment in research and development is expected to drive significant growth in the functional genomics market. Research and development involve a systematic effort to create, improve, and innovate products, processes, or knowledge through investigation and experimentation. As companies aim to stay competitive, they are increasingly allocating resources toward developing new products, advancing technologies, and seizing emerging market opportunities. This surge in investment is benefiting functional genomics by advancing the identification and analysis of gene functions, thus deepening our understanding of complex biological processes and supporting the development of targeted therapeutic strategies. For example, in December 2022, the UK Department of Health and Social Care announced a £105 million investment to accelerate the diagnosis of rare genetic conditions in newborns, aiming to provide life-saving treatments. This funding will enhance research into genomic healthcare by studying patients' DNA, further propelling the growth of the functional genomics market.

Key companies in the functional genomics market are focusing on advancing technologies such as high-throughput sequencing. This method enables the rapid and simultaneous sequencing of large amounts of DNA or RNA, allowing for broad-scale genetic analysis. For instance, in February 2025, Roche, a pharmaceutical company based in Switzerland, introduced sequencing by expansion (SBX) technology, a groundbreaking next-generation sequencing method. SBX chemistry, paired with an advanced sensor module, allows ultra-fast, high-throughput sequencing that is adaptable and scalable for various applications. The innovative technique converts DNA or RNA sequences into a detectable polymer called an Xpandomer, which is fifty times longer than the original nucleic acid. This process creates strong, low-noise signals for clear detection, utilizing a CMOS-based sensor for parallel processing and achieving high-accuracy, single-molecule nanopore sequencing with impressive speed and versatility.

In November 2022, Biocare Medical, a US-based medical equipment company, acquired Empire Genomics to expand its functional genomics capabilities. The acquisition aimed to enhance Biocare's molecular diagnostics and functional genomics expertise by integrating a portfolio of over one million biomarkers and rapid biomarker development into its existing diagnostic platforms. This move will strengthen Biocare's ability to support cancer research and personalized diagnostics. Empire Genomics, also based in the US, specializes in functional genomics and brings additional expertise to Biocare's growing capabilities.

Major players in the functional genomics market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Perkin Elmer Inc., Revvity Inc., Exact Sciences Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Integrated DNA Technologies Inc., Promega Corporation, Pacific Biosciences of California Inc., Genomics Ltd., MEDiC LLC, Enhanc3D Genomics Ltd., Samplix, Arima Genomics Inc., Phase Genomics Inc.

North America was the largest region in the functional genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in functional genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the functional genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The functional genomics market consists of revenues earned by entities by providing services such as gene expression profiling, epigenomic profiling, phenotypic screening, and variant effect analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The functional genomics market also includes sales of microarray scanners, thermal cyclers, fluorometers, and bioanalyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Functional Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on functional genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for functional genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The functional genomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Kits And Assays; Instruments
  • 2) By Technology: Next-Generation Sequencing (NGS); Microarray Analysis; CRISPR And Gene Editing Technologies; RNA Sequencing (RNA-Seq)
  • 3) By End-User: Academic And Research Institutes; Pharmaceutical And Biopharmaceutical Companies; Contract Research Organizations (CROs); Clinical Laboratories; Agricultural Biotechnology Companies
  • Subsegments:
  • 1) By Kits And Assays: PCR Kits; Microarray Kits; NGS Kits; Reagents; Enzymes
  • 2) By Instruments: Sequencers; Microarray Scanners; PCR Instruments; Automation Systems
  • Companies Mentioned: Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Merck KGaA; Becton Dickinson and Company; Agilent Technologies Inc.; Illumina Inc.; Perkin Elmer Inc.; Revvity Inc.; Exact Sciences Corporation; Bio-Rad Laboratories Inc.; QIAGEN NV; Integrated DNA Technologies Inc.; Promega Corporation; Pacific Biosciences of California Inc.; Genomics Ltd.; MEDiC LLC; Enhanc3D Genomics Ltd.; Samplix; Arima Genomics Inc.; Phase Genomics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Functional Genomics Market Characteristics

3. Functional Genomics Market Trends And Strategies

4. Functional Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Functional Genomics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Functional Genomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Functional Genomics Market Growth Rate Analysis
  • 5.4. Global Functional Genomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Functional Genomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Functional Genomics Total Addressable Market (TAM)

6. Functional Genomics Market Segmentation

  • 6.1. Global Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kits And Assays
  • Instruments
  • 6.2. Global Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Microarray Analysis
  • CRISPR And Gene Editing Technologies
  • RNA Sequencing (RNA-Seq)
  • Proteomics
  • 6.3. Global Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutes
  • Pharmaceutical And Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Clinical Laboratories
  • Agricultural Biotechnology Companies
  • 6.4. Global Functional Genomics Market, Sub-Segmentation Of Kits And Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Kits
  • Microarray Kits
  • NGS Kits
  • Reagents
  • Enzymes
  • 6.5. Global Functional Genomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencers
  • Microarray Scanners
  • PCR Instruments
  • Automation Systems

7. Functional Genomics Market Regional And Country Analysis

  • 7.1. Global Functional Genomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Functional Genomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Functional Genomics Market

  • 8.1. Asia-Pacific Functional Genomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Functional Genomics Market

  • 9.1. China Functional Genomics Market Overview
  • 9.2. China Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Functional Genomics Market

  • 10.1. India Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Functional Genomics Market

  • 11.1. Japan Functional Genomics Market Overview
  • 11.2. Japan Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Functional Genomics Market

  • 12.1. Australia Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Functional Genomics Market

  • 13.1. Indonesia Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Functional Genomics Market

  • 14.1. South Korea Functional Genomics Market Overview
  • 14.2. South Korea Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Functional Genomics Market

  • 15.1. Western Europe Functional Genomics Market Overview
  • 15.2. Western Europe Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Functional Genomics Market

  • 16.1. UK Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Functional Genomics Market

  • 17.1. Germany Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Functional Genomics Market

  • 18.1. France Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Functional Genomics Market

  • 19.1. Italy Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Functional Genomics Market

  • 20.1. Spain Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Functional Genomics Market

  • 21.1. Eastern Europe Functional Genomics Market Overview
  • 21.2. Eastern Europe Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Functional Genomics Market

  • 22.1. Russia Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Functional Genomics Market

  • 23.1. North America Functional Genomics Market Overview
  • 23.2. North America Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Functional Genomics Market

  • 24.1. USA Functional Genomics Market Overview
  • 24.2. USA Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Functional Genomics Market

  • 25.1. Canada Functional Genomics Market Overview
  • 25.2. Canada Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Functional Genomics Market

  • 26.1. South America Functional Genomics Market Overview
  • 26.2. South America Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Functional Genomics Market

  • 27.1. Brazil Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Functional Genomics Market

  • 28.1. Middle East Functional Genomics Market Overview
  • 28.2. Middle East Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Functional Genomics Market

  • 29.1. Africa Functional Genomics Market Overview
  • 29.2. Africa Functional Genomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Functional Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Functional Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Functional Genomics Market Competitive Landscape And Company Profiles

  • 30.1. Functional Genomics Market Competitive Landscape
  • 30.2. Functional Genomics Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Functional Genomics Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Perkin Elmer Inc.
  • 31.3. Revvity Inc.
  • 31.4. Exact Sciences Corporation
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. QIAGEN NV
  • 31.7. Integrated DNA Technologies Inc.
  • 31.8. Promega Corporation
  • 31.9. Pacific Biosciences of California Inc.
  • 31.10. Genomics Ltd.
  • 31.11. MEDiC LLC
  • 31.12. Enhanc3D Genomics Ltd.
  • 31.13. Samplix
  • 31.14. Arima Genomics Inc.
  • 31.15. Phase Genomics Inc.

32. Global Functional Genomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Functional Genomics Market

34. Recent Developments In The Functional Genomics Market

35. Functional Genomics Market High Potential Countries, Segments and Strategies

  • 35.1 Functional Genomics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Functional Genomics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Functional Genomics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제